December 17, 2019
CARLSBAD, Calif., Dec. 17, 2019 /PRNewswire/ — ChromaCode, Inc., a molecular diagnostics company, announced it has secured $28 million in Series C financing. The round was led by Northpond Ventures, a global firm dedicated to science … Continued
December 10, 2019
SAN JOSE, Calif., Dec. 10, 2019 /PRNewswire/ — Neuspera Medical Inc., a clinical stage, private, venture capital backed neuromodulation company, announced the receipt of an Investigational Device Exemption (IDE) from … Continued
December 04, 2019
— PGDx elio™ tissue complete assay will be used to identify candidates for pembrolizumab-based combination therapy — December 04, 2019 08:00 AM Eastern Standard Time BALTIMORE–(BUSINESS WIRE)–Personal Genome Diagnostics Inc. (PGDx), … Continued